X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3993) 3993
Publication (136) 136
Book Chapter (28) 28
Book Review (27) 27
Magazine Article (11) 11
Conference Proceeding (8) 8
Newsletter (4) 4
Book / eBook (2) 2
Data Set (1) 1
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3460) 3460
male (2155) 2155
female (1848) 1848
middle aged (1569) 1569
adult (1331) 1331
uremia - complications (1106) 1106
urology & nephrology (1075) 1075
renal dialysis (1046) 1046
uremia (976) 976
uremia - therapy (969) 969
aged (943) 943
uremia - drug therapy (818) 818
index medicus (762) 762
animals (717) 717
uremia - blood (662) 662
hemodialysis (565) 565
kidney failure, chronic - therapy (516) 516
uremia - metabolism (461) 461
rats (447) 447
kidney failure, chronic - complications (436) 436
nephrology (356) 356
renal dialysis - adverse effects (342) 342
uremia - physiopathology (337) 337
uremia - etiology (332) 332
chronic-renal-failure (301) 301
dialysis (296) 296
adolescent (295) 295
time factors (282) 282
hemodialysis-patients (274) 274
kidney failure, chronic - blood (251) 251
transplantation (249) 249
creatinine - blood (228) 228
erythropoietin - therapeutic use (221) 221
disease (216) 216
kidney diseases (216) 216
child (215) 215
kidney transplantation (207) 207
anemia - drug therapy (199) 199
risk factors (198) 198
chronic kidney-disease (195) 195
kidney failure, chronic - drug therapy (195) 195
treatment outcome (189) 189
medicine, general & internal (187) 187
peritoneal dialysis (179) 179
calcium - blood (178) 178
chronic kidney failure (178) 178
oxidative stress (176) 176
uremia - chemically induced (171) 171
parathyroid hormone - blood (170) 170
original paper (169) 169
chronic kidney disease (168) 168
hematology (168) 168
anemia - etiology (166) 166
mortality (163) 163
hypertension (162) 162
kidney failure, chronic - physiopathology (162) 162
anemia (160) 160
stage renal-disease (159) 159
aged, 80 and over (156) 156
inflammation (152) 152
rats, sprague-dawley (152) 152
chronic disease (147) 147
kidney failure, chronic - metabolism (143) 143
disease models, animal (142) 142
therapy (141) 141
blood urea nitrogen (140) 140
uremia - pathology (139) 139
pharmacology & pharmacy (134) 134
administration, oral (131) 131
atherosclerosis (129) 129
chronic renal failure (128) 128
dose-response relationship, drug (128) 128
erythropoietin (127) 127
prospective studies (122) 122
failure (121) 121
nephrectomy (121) 121
dialysis patients (120) 120
renal failure (116) 116
renal dialysis - methods (115) 115
medicine & public health (114) 114
metabolism (114) 114
secondary hyperparathyroidism (114) 114
hyperparathyroidism, secondary - drug therapy (112) 112
renal-failure (111) 111
recombinant proteins - therapeutic use (110) 110
blood pressure - drug effects (108) 108
recombinant proteins (108) 108
drug therapy, combination (107) 107
follow-up studies (107) 107
care and treatment (105) 105
blood pressure (104) 104
research article (104) 104
child, preschool (102) 102
end-stage renal disease (102) 102
hypertension - drug therapy (102) 102
calcium - metabolism (101) 101
pruritus - etiology (100) 100
peripheral vascular disease (98) 98
medicine (97) 97
peritoneal dialysis, continuous ambulatory (96) 96
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3551) 3551
German (117) 117
Italian (112) 112
French (61) 61
Japanese (38) 38
Polish (35) 35
Spanish (32) 32
Russian (28) 28
Chinese (20) 20
Danish (8) 8
Hungarian (8) 8
Bulgarian (7) 7
Swedish (7) 7
Czech (6) 6
Norwegian (5) 5
Turkish (3) 3
Finnish (2) 2
Hebrew (2) 2
Korean (2) 2
Portuguese (2) 2
Romanian (2) 2
Ukrainian (2) 2
Dutch (1) 1
Greek (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Society of Nephrology, ISSN 1046-6673, 2005, Volume 16, Issue 12, pp. 3742 - 3747
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 2015, Volume 309, Issue 11, pp. F967 - F979
Vascular calcification (VC) is a critical complication in patients with chronic kidney disease (CKD). The effects of spironolactone (SPL), a mineralocorticoid... 
Hyperphosphatemia | Vascular calcification | Chronic kidney disease | Spironolactone | Mineralocorticoid receptor | chronic kidney disease | OXIDATIVE STRESS | PHYSIOLOGY | vascular calcification | HEART-FAILURE | CELL-PROLIFERATION | SERUM | mineralocorticoid receptor | spironolactone | PHOSPHATE | hyperphosphatemia | INFLAMMATION | REGULATED KINASE 1 | ALDOSTERONE BLOCKADE | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | CHRONIC-RENAL-FAILURE | Kidney - pathology | Apoptosis - drug effects | Humans | Uremia - physiopathology | Uremia - drug therapy | Male | Aorta, Abdominal - drug effects | Hyperphosphatemia - blood | Kidney - metabolism | Time Factors | Tunica Media - metabolism | Mineralocorticoid Receptor Antagonists - pharmacology | Aortic Diseases - prevention & control | Disease Models, Animal | Kidney - drug effects | Biomarkers - blood | Vascular Calcification - pathology | Rats, Sprague-Dawley | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Signal Transduction - drug effects | Hyperphosphatemia - drug therapy | Renal Insufficiency, Chronic - chemically induced | Tunica Media - pathology | Tunica Media - drug effects | Receptors, Mineralocorticoid - metabolism | Aortic Diseases - blood | Aortic Diseases - chemically induced | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Receptors, Mineralocorticoid - drug effects | Uremia - chemically induced | Spironolactone - pharmacology | Uremia - pathology | Vascular Calcification - physiopathology | Aorta, Abdominal - pathology | Aorta, Abdominal - metabolism | Kidney - physiopathology | Aortic Diseases - pathology | Osteogenesis - drug effects | Vascular Calcification - blood | Adenine | Vascular Calcification - prevention & control | Renal Insufficiency, Chronic - pathology | Renal Insufficiency, Chronic - blood | Aortic Diseases - physiopathology | Animals | Uremia - blood | Vascular Calcification - chemically induced | Renin-Angiotensin System - drug effects | Antiandrogens | Calcification | Corticosteroids | Chronic kidney failure | Steroids | Cellular signal transduction | Observations | Health aspects
Journal Article
Kidney International, ISSN 0085-2538, 11/2017, Volume 92, Issue 5, pp. 1217 - 1222
Journal Article
Kidney International, ISSN 0085-2538, 05/2017, Volume 91, Issue 5, pp. 1104 - 1114
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0168396
Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated... 
RENAL FIBROSIS | ADHESION | ALBUMINURIA | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | DISEASE | RATS | CD4(+) T-CELLS | DYSFUNCTION | RECEPTOR AGONIST | PROGRESSION | Receptors, LDL - genetics | Atherosclerosis - drug therapy | Kidney - drug effects | Kidney - pathology | Atherosclerosis - genetics | Diabetes Mellitus, Type 2 - genetics | CD4-Positive T-Lymphocytes - metabolism | Kidney - immunology | Uremia - drug therapy | Male | Gene Knockout Techniques | Hypoglycemic Agents - pharmacology | Up-Regulation - drug effects | Animals | Hypoglycemic Agents - administration & dosage | Liraglutide - pharmacology | Fibrosis | CD8-Positive T-Lymphocytes - metabolism | Mice | Uremia - immunology | Liraglutide - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Disease Models, Animal | Complications and side effects | Atherosclerosis | Dosage and administration | Research | Kidney diseases | Drug therapy | Liraglutide | Flow cytometry | Collagen (type I) | Nephrology | Syngeneic grafts | CD8 antigen | Homeostasis | Smooth muscle | Biochemistry | Lymphocytes T | Genotype & phenotype | Nephrectomy | Rodents | Aorta | Lipoprotein (low density) receptors | Diabetes mellitus (non-insulin dependent) | Kidneys | Diabetes mellitus | Markers | Health risks | Histology | Inflammation | CD4 antigen | Studies | Cytometry | Monocytes | Arteriosclerosis | Receptor density | Diabetes | Uremia | Cardiovascular diseases
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 06/2012, Volume 27, Issue 6, pp. 2206 - 2212
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 01/2019, Volume 32, Issue 1, pp. 34 - 44
Abstract BACKGROUND In uremic animals, vitamin D receptor (VDR) agonists like paricalcitol (Pc) attenuate cardiac hypertrophy, but this effect has not been... 
blood pressure | VITAMIN-D | paricalcitol | vitamin D | NFAT/calcineurin axis | LEFT-VENTRICULAR HYPERTROPHY | CHILDREN | GENE | RENIN-ANGIOTENSIN SYSTEM | CARDIAC-HYPERTROPHY | GROWTH-FACTOR 23 | PERIPHERAL VASCULAR DISEASE | cardiac hypertrophy | CHRONIC KIDNEY-DISEASE | CKD | FGF23 | hypertension | EXPRESSION | renin-angiotensin-system | CALCITRIOL | Receptor, Fibroblast Growth Factor, Type 4 - metabolism | Humans | Uremia - physiopathology | Cardio-Renal Syndrome - metabolism | Uremia - drug therapy | Cardiomyopathies - prevention & control | Male | Uremia - metabolism | Cardiomyopathies - physiopathology | Uremia - pathology | Female | Retrospective Studies | Drug Therapy, Combination | Child | Cardio-Renal Syndrome - physiopathology | Disease Models, Animal | Kidney Failure, Chronic - physiopathology | Signal Transduction | Kidney Failure, Chronic - drug therapy | Ventricular Function, Left - drug effects | Cardio-Renal Syndrome - prevention & control | Pyrimidines - pharmacology | Receptors, Calcitriol - metabolism | Rats, Sprague-Dawley | Kidney Failure, Chronic - metabolism | Animals | Heart Ventricles - physiopathology | Fibroblast Growth Factors - blood | Receptors, Calcitriol - agonists | Cardiomyopathies - metabolism | Adolescent | Ergocalciferols - pharmacology | Heart Ventricles - metabolism | Receptor, Fibroblast Growth Factor, Type 4 - antagonists & inhibitors | Ventricular Remodeling - drug effects | Heart Ventricles - drug effects | calcineurin axis | Original Contributions | renin–angiotensin-system | NFAT
Journal Article
Journal Article
Journal Article